ArticleTranslational stroke research2015

Preclinical evaluation of recombinant T cell receptor ligand RTL1000 as a therapeutic agent in ischemic stroke.

Wenbin Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.